1. Home
  2. HCM

as of 02-03-2026 12:18pm EST

$14.49
$0.07
-0.48%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Founded: 2000 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 2.7B IPO Year: N/A
Target Price: $13.75 AVG Volume (30 days): 52.8K
Analyst Decision: Sell Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.53 EPS Growth: N/A
52 Week Low/High: $11.51 - $19.50 Next Earning Date: 03-18-2026
Revenue: $602,197,000 Revenue Growth: -1.41%
Revenue Growth (this year): -2.93% Revenue Growth (next year): 15.54%

AI-Powered HCM Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 73.86%
73.86%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: